Analyst Ratings for Edwards Lifesciences (EW)
EW Rating Summary
EW Price Target Summary
- Highest: $110.00 (Barclays)
- Lowest: $85.00 (Canaccord)
- Average: $95.92
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$95.92 (+12.7%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
Avg. $ Target:
$95.92 (+12.7%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/1/2026 | Wolfe Research | Mike Polark | Upgrade | Outperform (Peerperform) |
92.00 (N/A) |
80.08 (85.11) |
6.28% | Details |
| 1/9/2026 | TD Cowen » Updated 6/2/2026 |
Joshua Jennings | Upgrade | Buy (Hold) |
104.00 (97.00) |
84.58 (85.11) |
0.63% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
